GreenLight Biosciences (GRNA) Filings

424B3

GRNA GreenLight Biosciences Inc

9 Mar 23

Prospectus supplement

7:07am

8-K

GRNA GreenLight Biosciences Inc

9 Mar 23

GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day

7:03am

424B3

GRNA GreenLight Biosciences Inc

7 Mar 23

Prospectus supplement

7:18am

8-K

GRNA GreenLight Biosciences Inc

7 Mar 23

GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day

7:06am

SC 13G/A

GRNA GreenLight Biosciences Inc

14 Feb 23

GreenLight Biosciences Holdings, PBC / Cormorant Asset Management ownership change

3:13pm

SC 13G/A

GRNA GreenLight Biosciences Inc

14 Feb 23

GreenLight Biosciences Holdings, PBC / Builders Vision ownership change

12:46pm

424B3

GRNA GreenLight Biosciences Inc

1 Feb 23

Prospectus supplement

7:43am

8-K

GRNA GreenLight Biosciences Inc

1 Feb 23

GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate

7:29am

SC 13G/A

Highbridge Capital Management LLC

30 Jan 23

GreenLight Biosciences Holdings, PBC / HIGHBRIDGE CAPITAL MANAGEMENT ownership change

3:04pm

424B3

GRNA GreenLight Biosciences Inc

9 Jan 23

Prospectus supplement

7:31am

8-K

GRNA GreenLight Biosciences Inc

9 Jan 23

Entry into a Material Definitive Agreement

7:27am

424B3

GRNA GreenLight Biosciences Inc

9 Nov 22

Prospectus supplement

5:27pm

8-K

GRNA GreenLight Biosciences Inc

9 Nov 22

Results of Operations and Financial Condition

5:13pm

424B3

GRNA GreenLight Biosciences Inc

12 Oct 22

Prospectus supplement

6:53am

8-K

GRNA GreenLight Biosciences Inc

12 Oct 22

Cost Associated with Exit or Disposal Activities

6:50am

424B3

GRNA GreenLight Biosciences Inc

6 Oct 22

Prospectus supplement

5:15pm

EFFECT

GRNA GreenLight Biosciences Inc

6 Oct 22

Notice of effectiveness

12:15am

CORRESP

GRNA GreenLight Biosciences Inc

4 Oct 22

Correspondence with SEC

12:00am

UPLOAD

GRNA GreenLight Biosciences Inc

3 Oct 22

Letter from SEC

12:00am